Lakewood-Amedex Biotherapeutics
(NASDAQ) LABT
Lakewood-Amedex Biotherapeutics Financials at a Glance
Market Cap
$21.03M
Revenue (TTM)
$0.00
Net Income (TTM)
$3.85
EPS (TTM)
$-0.69
P/E Ratio
-2.17
Dividend
$0.00
Beta (Volatility)
4.00 (High)
Dividend
$0.00
Beta (Volatility)
4.00 (High)
Price
$1.50
Volume
5,480
Open
$1.70
Price
$1.50
Volume
5,480
Open
$1.70
Previous Close
$1.50
Daily Range
$1.48 - $1.70
52-Week Range
$1.41 - $9.82
Dividend
$0.00
Beta (Volatility)
4.00 (High)
Price
$1.50
Volume
5,480
Open
$1.70
Previous Close
$1.50
Daily Range
$1.48 - $1.70
52-Week Range
$1.41 - $9.82
LABT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lakewood-Amedex Biotherapeutics
Industry
Biotechnology
Sector
Health CareEmployees
5
CEO
Kelvin Cooper, PhD
Website
www.lakewoodamedex.comHeadquarters
University Park, FL 34201, US
LABT Financials
Key Financial Metrics (TTM)
Gross Margin
N/A
Operating Margin
N/A
Net Income Margin
N/A
Return on Equity
0%
Return on Capital
N/A
Return on Assets
N/A
Earnings Yield
-46.08%
Dividend Yield
0.00%
Payout Ratio
N/A
Stock Overview
Market Cap
$21.03M
Shares Outstanding
14.02M
Volume
5.48K
Avg. Volume
3.12M
Financials (TTM)
Gross Profit
N/A
Operating Income
N/A
EBITDA
N/A
Operating Cash Flow
N/A
Capital Expenditure
N/A
Free Cash Flow
N/A
Cash & ST Invst.
N/A
Total Debt
N/A
Lakewood-Amedex Biotherapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.03
+1.0%
Gross Margin
N/A
N/A
Market Cap
$21.03M
N/A
Market Cap/Employee
N/A
N/A
Employees
5
N/A
Net Income
$0.74
+0.9%
EBITDA
$0.68
+0.8%
Quarterly Fundamentals
Net Cash
$0.24
+0.3%
Accounts Receivable
N/A
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.04
+0.3%
Short Term Debt
$1.62
+14.4%
Return on Assets
-495.77%
N/A
Return on Invested Capital
N/A
N/A
Free Cash Flow
$0.42
+0.6%
Operating Cash Flow
$0.42
+0.6%